Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1541709
PUBLISHER: IMARC | PRODUCT CODE: 1541709
Sickle Cell Disease Treatment Market Report by Treatment Type (Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant), End User (Hospitals, Diagnostic Centers, and Others), and Region 2024-2032
PUBLISHED:
PAGES: 140 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global sickle cell disease treatment market size reached US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.9 Billion by 2032, exhibiting a growth rate (CAGR) of 14% during 2024-2032.
Sickle cell disease (SCD) is a genetic red blood cell (RBC) disorder that affects hemoglobin, a protein that carries oxygen throughout the body. It leads to many complications, such as acute chest syndrome, anemia, and vaso-occlusive crisis (VOC). At present, blood and bone marrow transplant is commonly suggested by doctors for treating SCD. It involves replacing affected bone marrow with a healthy substitute received from a donor. Other effective treatments, such as medications and blood transfusions, are also being utilized as they can reduce specific symptoms and prolong the life of patients.
A considerable increase in the number of individuals suffering from SCD represents one of the significant factors influencing the demand for new medications that can treat the condition effectively. As a result, the health regulatory authorities of numerous countries are focusing on fast-track approval of new treatment methods. For instance, the United States Food and Drug Administration (USFDA) approved a new medicine in 2019 to reduce the pain experienced by adults and children with SCD. Additionally, government authorities are supporting research and development (R&D) activities to encourage researchers and pharmaceutical companies to develop novel treatments. For instance, researchers at the National Heart, Lung, and Blood Institute (NHLBI) in the US are working on genetic therapies that can restore a missing gene or add a new DNA strain to improve the functioning of cells. These innovations, along with the rising disposable incomes and the growing awareness among individuals about the available healthcare services, are anticipated to contribute to market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global sickle cell disease treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on treatment type and end user.
Breakup by Treatment Type:
Blood Transfusion
Pharmacotherapy
Bone Marrow Transplant
Breakup by End User:
Hospitals
Diagnostic Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca Plc, Baxter International Inc., bluebird bio Inc., Bristol-Myers Squibb Company, CRISPR Therapeutics, Emmaus Medical Inc., Global Blood Therapeutics Inc., GlycoMimetics Inc., Novartis AG, Pfizer Inc. and Sangamo Therapeutics.
Key Questions Answered in This Report
- 1. What was the size of the global sickle cell disease treatment market in 2023?
- 2. What is the expected growth rate of the global sickle cell disease treatment market during 2024-2032?
- 3. What has been the impact of COVID-19 on the global sickle cell disease treatment market?
- 4. What are the key factors driving the global sickle cell disease treatment market?
- 5. What is the breakup of the global sickle cell disease treatment market based on the treatment type?
- 6. What is the breakup of the global sickle cell disease treatment market based on the end user?
- 7. What are the key regions in the global sickle cell disease treatment market?
- 8. Who are the key players/companies in the global sickle cell disease treatment market?
Product Code: SR112024A4076
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Sickle Cell Disease Treatment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Treatment Type
- 6.1 Blood Transfusion
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Pharmacotherapy
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Bone Marrow Transplant
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by End User
- 7.1 Hospitals
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Diagnostic Centers
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 AstraZeneca Plc
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 Baxter International Inc.
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 bluebird bio Inc.
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.3.4 SWOT Analysis
- 13.3.4 Bristol-Myers Squibb Company
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 CRISPR Therapeutics
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.6 Emmaus Medical Inc.
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.7 Global Blood Therapeutics Inc.
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.8 GlycoMimetics Inc.
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.9 Novartis AG
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.9.3 Financials
- 13.3.9.4 SWOT Analysis
- 13.3.10 Pfizer Inc.
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.10.3 Financials
- 13.3.10.4 SWOT Analysis
- 13.3.11 Sangamo Therapeutics
- 13.3.11.1 Company Overview
- 13.3.11.2 Product Portfolio
- 13.3.11.3 Financials
- 13.3.11.4 SWOT Analysis
- 13.3.1 AstraZeneca Plc
Product Code: SR112024A4076
List of Figures
- Figure 1: Global: Sickle Cell Disease Treatment Market: Major Drivers and Challenges
- Figure 2: Global: Sickle Cell Disease Treatment Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Sickle Cell Disease Treatment Market: Breakup by Treatment Type (in %), 2023
- Figure 5: Global: Sickle Cell Disease Treatment Market: Breakup by End User (in %), 2023
- Figure 6: Global: Sickle Cell Disease Treatment Market: Breakup by Region (in %), 2023
- Figure 7: Global: Sickle Cell Disease Treatment (Blood Transfusion) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 8: Global: Sickle Cell Disease Treatment (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 9: Global: Sickle Cell Disease Treatment (Pharmacotherapy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Sickle Cell Disease Treatment (Pharmacotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Sickle Cell Disease Treatment (Bone Marrow Transplant) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Sickle Cell Disease Treatment (Bone Marrow Transplant) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Sickle Cell Disease Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Sickle Cell Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Sickle Cell Disease Treatment (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Sickle Cell Disease Treatment (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Sickle Cell Disease Treatment (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Sickle Cell Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: North America: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: North America: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: United States: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: United States: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Canada: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Canada: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Asia-Pacific: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Asia-Pacific: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: China: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: China: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Japan: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Japan: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: India: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: India: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: South Korea: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: South Korea: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Australia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Australia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: Indonesia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: Indonesia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: Europe: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: Europe: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: Germany: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: Germany: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: France: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: France: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: United Kingdom: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: United Kingdom: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: Italy: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: Italy: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: Spain: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: Spain: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: Russia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: Russia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: Latin America: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: Latin America: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Brazil: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Brazil: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Mexico: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Mexico: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: Middle East and Africa: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: Middle East and Africa: Sickle Cell Disease Treatment Market: Breakup by Country (in %), 2023
- Figure 67: Middle East and Africa: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Global: Sickle Cell Disease Treatment Industry: SWOT Analysis
- Figure 69: Global: Sickle Cell Disease Treatment Industry: Value Chain Analysis
- Figure 70: Global: Sickle Cell Disease Treatment Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Sickle Cell Disease Treatment Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
- Table 3: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by End User (in Million US$), 2024-2032
- Table 4: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 5: Global: Sickle Cell Disease Treatment Market: Competitive Structure
- Table 6: Global: Sickle Cell Disease Treatment Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.